Anwaar Saeed, Rui-Hua Xu, Harshabad Singh, Jason Timothy Henry, Alexander I. Spira, Nicholas C. DeVito, Nataliya V. Uboha, Dani Ran Castillo, Naomi Fei, Dianna Hanna, Heshui Wu, Min Tao, Zhenhua Liu, Kelan Chen, Grace H. McGregor, Satya Das, Hui Zou, Ming Wang, Rita Laeufle, Michael J. Overman. "Spevatamig (PT886), a claudin 18.2 (CLDN18.2)/CD47 bispecific antibody, in combination with gemcitabine plus nab-paclitaxel (GnP) in frontline (1L) treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4192